Volume | 9,769 |
|
|||||
News | - | ||||||
Day High | 1.40 | Low High |
|||||
Day Low | 1.35 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
RenovoRx Inc | RNXT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.35 | 1.35 | 1.40 | 1.40 | 1.35 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
94 | 9,769 | $ 1.38 | $ 13,500 | - | 0.5306 - 3.29 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:17:11 | 20 | $ 1.40 | USD |
RenovoRx Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
14.97M | 10.69M | - | 0 | -10.23M | -0.96 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
RenovoRx News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNXT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.48 | 1.48 | 1.35 | 1.38 | 22,182 | -0.08 | -5.41% |
1 Month | 1.22 | 1.48 | 1.14 | 1.33 | 18,796 | 0.18 | 14.75% |
3 Months | 1.26 | 1.86 | 1.10 | 1.32 | 39,098 | 0.14 | 11.11% |
6 Months | 0.62 | 2.35 | 0.5306 | 1.43 | 67,572 | 0.78 | 125.81% |
1 Year | 2.06 | 3.29 | 0.5306 | 2.20 | 189,023 | -0.66 | -32.04% |
3 Years | 8.25 | 16.74 | 0.5306 | 7.73 | 455,605 | -6.85 | -83.03% |
5 Years | 8.25 | 16.74 | 0.5306 | 7.73 | 455,605 | -6.85 | -83.03% |
RenovoRx Description
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. |